16:17 EST BioLineRx files $250M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BLRX:
- BioLineRx doses first patient in Phase 1 clinical trial of motixafortide
- Options Volatility and Implied Earnings Moves Today, November 20, 2023
- Options Volatility and Implied Earnings Moves This Week, November 20 – November 23, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate and Portfolio Updates
- BLRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?